リポソームドラッグデリバリーのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Liposome Drug Delivery Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16206 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

リポソームドラッグデリバリー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のリポソームドラッグデリバリーの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のリポソームドラッグデリバリーの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 リポソームドラッグデリバリー市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他 用途別セグメントは次のように区分されます。 ・真菌感染症治療、癌・腫瘍治療、その他 世界のリポソームドラッグデリバリー市場の主要な市場プレーヤーは以下のとおりです。 ・Gilead Sciences、Pacira、Sun Pharmaceutical、Johnson & Johnson、Luye Pharma、Sigma-Tau、Ipsen (Onivyde)、CSPC、Teva Pharmaceutical、Novartis、Fudan-Zhangjiang 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、リポソームドラッグデリバリー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なリポソームドラッグデリバリーメーカーの企業概要、2019年～2021年までのリポソームドラッグデリバリーの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なリポソームドラッグデリバリーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別リポソームドラッグデリバリーの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのリポソームドラッグデリバリーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのリポソームドラッグデリバリー市場予測を収録しています。 ・第12、13、14章では、リポソームドラッグデリバリーの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Gilead Sciences、Pacira、Sun Pharmaceutical、Johnson & Johnson、Luye Pharma、Sigma-Tau、Ipsen (Onivyde)、CSPC、Teva Pharmaceutical、Novartis、Fudan-Zhangjiang ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他 ・用途別分析2016年-2026年：真菌感染症治療、癌・腫瘍治療、その他 ・リポソームドラッグデリバリーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・リポソームドラッグデリバリーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・リポソームドラッグデリバリーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・リポソームドラッグデリバリーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・リポソームドラッグデリバリーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Liposome Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Liposome Drug Delivery size is estimated to be XX million in 2021 from USD 3408.9 million in 2020, with a change of XX% between 2020 and 2021. The global Liposome Drug Delivery market size is expected to grow at a CAGR of 12.2% for the next five years.

Market segmentation
Liposome Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others

Market segment by Application can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Others

The key market players for global Liposome Drug Delivery market are listed below:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Liposome Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liposome Drug Delivery, with price, sales, revenue and global market share of Liposome Drug Delivery from 2019 to 2021.
Chapter 3, the Liposome Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposome Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Liposome Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Liposome Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Liposome Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liposome Drug Delivery Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Liposome Drug Delivery Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Global Liposome Drug Delivery Market Size & Forecast
1.4.1 Global Liposome Drug Delivery Sales in Value (2016-2026))
1.4.2 Global Liposome Drug Delivery Sales in Volume (2016-2026)
1.4.3 Global Liposome Drug Delivery Price by Type (2016-2026) & (USD/Vial)
1.5 Global Liposome Drug Delivery Production Capacity Analysis
1.5.1 Global Liposome Drug Delivery Total Production Capacity (2016-2026)
1.5.2 Global Liposome Drug Delivery Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Liposome Drug Delivery Market Drivers
1.6.2 Liposome Drug Delivery Market Restraints
1.6.3 Liposome Drug Delivery Trends Analysis
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Liposome Drug Delivery Product and Services
2.1.4 Gilead Sciences Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Pacira
2.2.1 Pacira Details
2.2.2 Pacira Major Business
2.2.3 Pacira Liposome Drug Delivery Product and Services
2.2.4 Pacira Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sun Pharmaceutical
2.3.1 Sun Pharmaceutical Details
2.3.2 Sun Pharmaceutical Major Business
2.3.3 Sun Pharmaceutical Liposome Drug Delivery Product and Services
2.3.4 Sun Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Liposome Drug Delivery Product and Services
2.4.4 Johnson & Johnson Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Luye Pharma
2.5.1 Luye Pharma Details
2.5.2 Luye Pharma Major Business
2.5.3 Luye Pharma Liposome Drug Delivery Product and Services
2.5.4 Luye Pharma Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sigma-Tau
2.6.1 Sigma-Tau Details
2.6.2 Sigma-Tau Major Business
2.6.3 Sigma-Tau Liposome Drug Delivery Product and Services
2.6.4 Sigma-Tau Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Ipsen (Onivyde)
2.7.1 Ipsen (Onivyde) Details
2.7.2 Ipsen (Onivyde) Major Business
2.7.3 Ipsen (Onivyde) Liposome Drug Delivery Product and Services
2.7.4 Ipsen (Onivyde) Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 CSPC
2.8.1 CSPC Details
2.8.2 CSPC Major Business
2.8.3 CSPC Liposome Drug Delivery Product and Services
2.8.4 CSPC Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business
2.9.3 Teva Pharmaceutical Liposome Drug Delivery Product and Services
2.9.4 Teva Pharmaceutical Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Liposome Drug Delivery Product and Services
2.10.4 Novartis Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Fudan-Zhangjiang
2.11.1 Fudan-Zhangjiang Details
2.11.2 Fudan-Zhangjiang Major Business
2.11.3 Fudan-Zhangjiang Liposome Drug Delivery Product and Services
2.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Liposome Drug Delivery Sales by Manufacturer
3.1 Global Liposome Drug Delivery Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Liposome Drug Delivery Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Liposome Drug Delivery
3.4 Market Concentration Rate
3.4.1 Top 3 Liposome Drug Delivery Manufacturer Market Share
3.4.2 Top 6 Liposome Drug Delivery Manufacturer Market Share
3.5 Global Liposome Drug Delivery Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Liposome Drug Delivery Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Liposome Drug Delivery Market Size by Region
4.1.1 Global Liposome Drug Delivery Sales in Volume by Region (2016-2026)
4.1.2 Global Liposome Drug Delivery Revenue by Region (2016-2026)
4.2 North America Liposome Drug Delivery Revenue (2016-2026)
4.3 Europe Liposome Drug Delivery Revenue (2016-2026)
4.4 Asia-Pacific Liposome Drug Delivery Revenue (2016-2026)
4.5 South America Liposome Drug Delivery Revenue (2016-2026)
4.6 Middle East and Africa Liposome Drug Delivery Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Liposome Drug Delivery Sales in Volume by Type (2016-2026)
5.2 Global Liposome Drug Delivery Revenue by Type (2016-2026)
5.3 Global Liposome Drug Delivery Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Liposome Drug Delivery Sales in Volume by Application (2016-2026)
6.2 Global Liposome Drug Delivery Revenue by Application (2016-2026)
6.3 Global Liposome Drug Delivery Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Liposome Drug Delivery Sales by Type (2016-2026)
7.2 North America Liposome Drug Delivery Sales by Application (2016-2026)
7.3 North America Liposome Drug Delivery Market Size by Country
7.3.1 North America Liposome Drug Delivery Sales in Volume by Country (2016-2026)
7.3.2 North America Liposome Drug Delivery Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Liposome Drug Delivery Sales by Type (2016-2026)
8.2 Europe Liposome Drug Delivery Sales by Application (2016-2026)
8.3 Europe Liposome Drug Delivery Market Size by Country
8.3.1 Europe Liposome Drug Delivery Sales in Volume by Country (2016-2026)
8.3.2 Europe Liposome Drug Delivery Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Liposome Drug Delivery Sales by Type (2016-2026)
9.2 Asia-Pacific Liposome Drug Delivery Sales by Application (2016-2026)
9.3 Asia-Pacific Liposome Drug Delivery Market Size by Region
9.3.1 Asia-Pacific Liposome Drug Delivery Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Liposome Drug Delivery Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Liposome Drug Delivery Sales by Type (2016-2026)
10.2 South America Liposome Drug Delivery Sales by Application (2016-2026)
10.3 South America Liposome Drug Delivery Market Size by Country
10.3.1 South America Liposome Drug Delivery Sales in Volume by Country (2016-2026)
10.3.2 South America Liposome Drug Delivery Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Liposome Drug Delivery Sales by Type (2016-2026)
11.2 Middle East & Africa Liposome Drug Delivery Sales by Application (2016-2026)
11.3 Middle East & Africa Liposome Drug Delivery Market Size by Country
11.3.1 Middle East & Africa Liposome Drug Delivery Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Liposome Drug Delivery Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Liposome Drug Delivery Typical Distributors
12.3 Liposome Drug Delivery Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Liposome Drug Delivery Revenue by Type, (USD Million), 2021-2026
Table 2. Global Liposome Drug Delivery Revenue by Application, (USD Million), 2021-2026
Table 3. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 4. Gilead Sciences Major Business
Table 5. Gilead Sciences Liposome Drug Delivery Product and Services
Table 6. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pacira Basic Information, Manufacturing Base and Competitors
Table 8. Pacira Major Business
Table 9. Pacira Liposome Drug Delivery Product and Services
Table 10. Pacira Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Sun Pharmaceutical Major Business
Table 13. Sun Pharmaceutical Liposome Drug Delivery Product and Services
Table 14. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Liposome Drug Delivery Product and Services
Table 18. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Luye Pharma Major Business
Table 21. Luye Pharma Liposome Drug Delivery Product and Services
Table 22. Luye Pharma Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sigma-Tau Basic Information, Manufacturing Base and Competitors
Table 24. Sigma-Tau Major Business
Table 25. Sigma-Tau Liposome Drug Delivery Product and Services
Table 26. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Ipsen (Onivyde) Basic Information, Manufacturing Base and Competitors
Table 28. Ipsen (Onivyde) Major Business
Table 29. Ipsen (Onivyde) Liposome Drug Delivery Product and Services
Table 30. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. CSPC Basic Information, Manufacturing Base and Competitors
Table 32. CSPC Major Business
Table 33. CSPC Liposome Drug Delivery Product and Services
Table 34. CSPC Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Teva Pharmaceutical Major Business
Table 37. Teva Pharmaceutical Liposome Drug Delivery Product and Services
Table 38. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novartis Basic Information, Manufacturing Base and Competitors
Table 40. Novartis Major Business
Table 41. Novartis Liposome Drug Delivery Product and Services
Table 42. Novartis Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Fudan-Zhangjiang Basic Information, Manufacturing Base and Competitors
Table 44. Fudan-Zhangjiang Major Business
Table 45. Fudan-Zhangjiang Liposome Drug Delivery Product and Services
Table 46. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Price (USD/Vial), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Liposome Drug Delivery Sales by Manufacturer (2019-2021e) & (K Vial)
Table 48. Global Liposome Drug Delivery Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Liposome Drug Delivery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Liposome Drug Delivery Production Capacity by Company, (K Vial): 2020 VS 2021
Table 51. Head Office and Liposome Drug Delivery Production Site of Key Manufacturer
Table 52. Liposome Drug Delivery New Entrant and Capacity Expansion Plans
Table 53. Liposome Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 54. Global Liposome Drug Delivery Sales by Region (2016-2021e) & (K Vial)
Table 55. Global Liposome Drug Delivery Sales by Region (2021-2026) & (K Vial)
Table 56. Global Liposome Drug Delivery Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Liposome Drug Delivery Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Liposome Drug Delivery Sales by Type (2016-2021e) & (K Vial)
Table 59. Global Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial)
Table 60. Global Liposome Drug Delivery Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Liposome Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Liposome Drug Delivery Price by Type (2016-2021e) & (USD/Vial)
Table 63. Global Liposome Drug Delivery Price by Type (2021-2026) & (USD/Vial)
Table 64. Global Liposome Drug Delivery Sales by Application (2016-2021e) & (K Vial)
Table 65. Global Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial)
Table 66. Global Liposome Drug Delivery Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Liposome Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Liposome Drug Delivery Price by Application (2016-2021e) & (USD/Vial)
Table 69. Global Liposome Drug Delivery Price by Application (2021-2026) & (USD/Vial)
Table 70. North America Liposome Drug Delivery Sales by Country (2016-2021e) & (K Vial)
Table 71. North America Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial)
Table 72. North America Liposome Drug Delivery Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Liposome Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Liposome Drug Delivery Sales by Type (2016-2021e) & (K Vial)
Table 75. North America Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial)
Table 76. North America Liposome Drug Delivery Sales by Application (2016-2021e) & (K Vial)
Table 77. North America Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial)
Table 78. Europe Liposome Drug Delivery Sales by Country (2016-2021e) & (K Vial)
Table 79. Europe Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial)
Table 80. Europe Liposome Drug Delivery Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Liposome Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Liposome Drug Delivery Sales by Type (2016-2021e) & (K Vial)
Table 83. Europe Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial)
Table 84. Europe Liposome Drug Delivery Sales by Application (2016-2021e) & (K Vial)
Table 85. Europe Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial)
Table 86. Asia-Pacific Liposome Drug Delivery Sales by Region (2016-2021e) & (K Vial)
Table 87. Asia-Pacific Liposome Drug Delivery Sales by Region (2021-2026) & (K Vial)
Table 88. Asia-Pacific Liposome Drug Delivery Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Liposome Drug Delivery Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Liposome Drug Delivery Sales by Type (2016-2021e) & (K Vial)
Table 91. Asia-Pacific Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial)
Table 92. Asia-Pacific Liposome Drug Delivery Sales by Application (2016-2021e) & (K Vial)
Table 93. Asia-Pacific Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial)
Table 94. South America Liposome Drug Delivery Sales by Country (2016-2021e) & (K Vial)
Table 95. South America Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial)
Table 96. South America Liposome Drug Delivery Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Liposome Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Liposome Drug Delivery Sales by Type (2016-2021e) & (K Vial)
Table 99. South America Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial)
Table 100. South America Liposome Drug Delivery Sales by Application (2016-2021e) & (K Vial)
Table 101. South America Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial)
Table 102. Middle East & Africa Liposome Drug Delivery Sales by Country (2016-2021e) & (K Vial)
Table 103. Middle East & Africa Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial)
Table 104. Middle East & Africa Liposome Drug Delivery Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Liposome Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Liposome Drug Delivery Sales by Type (2016-2021e) & (K Vial)
Table 107. Middle East & Africa Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial)
Table 108. Middle East & Africa Liposome Drug Delivery Sales by Application (2016-2021e) & (K Vial)
Table 109. Middle East & Africa Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Liposome Drug Delivery Typical Distributors
Table 113. Liposome Drug Delivery Typical Customers
List of Figures
Figure 1. Liposome Drug Delivery Picture
Figure 2. Global Liposome Drug Delivery Sales Market Share by Type in 2020
Figure 3. Liposomal Doxorubicin
Figure 4. Liposomal Amphoteracin B
Figure 5. Liposomal Paclitaxel
Figure 6. Others
Figure 7. Global Liposome Drug Delivery Sales Market Share by Application in 2020
Figure 8. Fungal Infection Therapy
Figure 9. Cancer & Tumor Therapy
Figure 10. Others
Figure 11. Global Liposome Drug Delivery Market Size, (USD Million) & (K Vial): 2020 VS 2021 VS 2026
Figure 12. Global Liposome Drug Delivery Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Liposome Drug Delivery Sales (2016-2026) & (K Vial)
Figure 14. Global Liposome Drug Delivery Price by Type (2016-2026) & (USD/Vial)
Figure 15. Global Liposome Drug Delivery Production Capacity (2016-2026) & (K Vial)
Figure 16. Global Liposome Drug Delivery Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Liposome Drug Delivery Market Drivers
Figure 18. Liposome Drug Delivery Market Restraints
Figure 19. Liposome Drug Delivery Market Trends
Figure 20. Global Liposome Drug Delivery Sales Market Share by Manufacturer in 2020
Figure 21. Global Liposome Drug Delivery Revenue Market Share by Manufacturer in 2020
Figure 22. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Liposome Drug Delivery Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Liposome Drug Delivery Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Liposome Drug Delivery Sales Market Share by Region (2016-2026)
Figure 26. Global Liposome Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 27. North America Liposome Drug Delivery Revenue (2016-2026) & (USD Million)
Figure 28. Europe Liposome Drug Delivery Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Liposome Drug Delivery Revenue (2016-2026) & (USD Million)
Figure 30. South America Liposome Drug Delivery Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Liposome Drug Delivery Revenue (2016-2026) & (USD Million)
Figure 32. Global Liposome Drug Delivery Sales Market Share by Type (2016-2026)
Figure 33. Global Liposome Drug Delivery Revenue Market Share by Type (2016-2026)
Figure 34. Global Liposome Drug Delivery Price by Type (2016-2026) & (USD/Vial)
Figure 35. Global Liposome Drug Delivery Sales Market Share by Application (2016-2026)
Figure 36. Global Liposome Drug Delivery Revenue Market Share by Application (2016-2026)
Figure 37. Global Liposome Drug Delivery Price by Application (2016-2026) & (USD/Vial)
Figure 38. North America Liposome Drug Delivery Sales Market Share by Type (2016-2026)
Figure 39. North America Liposome Drug Delivery Sales Market Share by Application (2016-2026)
Figure 40. North America Liposome Drug Delivery Sales Market Share by Country (2016-2026)
Figure 41. North America Liposome Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 42. United States Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Liposome Drug Delivery Sales Market Share by Type (2016-2026)
Figure 46. Europe Liposome Drug Delivery Sales Market Share by Application (2016-2026)
Figure 47. Europe Liposome Drug Delivery Sales Market Share by Country (2016-2026)
Figure 48. Europe Liposome Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 49. Germany Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Liposome Drug Delivery Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Liposome Drug Delivery Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Liposome Drug Delivery Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Liposome Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 58. China Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Liposome Drug Delivery Sales Market Share by Type (2016-2026)
Figure 65. South America Liposome Drug Delivery Sales Market Share by Application (2016-2026)
Figure 66. South America Liposome Drug Delivery Sales Market Share by Country (2016-2026)
Figure 67. South America Liposome Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Liposome Drug Delivery Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Liposome Drug Delivery Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Liposome Drug Delivery Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Liposome Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Liposome Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

---